serine has been researched along with fosbretabulin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, Y; Hatanaka, T; Hori, K; Morinaga, Y; Nakagawa, R; Nihei, Y; Ohishi, K; Ohsumi, K; Okano, A; Saito, S; Sato, Y; Suga, Y; Tsuji, T; Tsuruo, T | 1 |
| Hori, K; Nihei, Y; Saito, S; Sato, Y; Suzuki, M | 1 |
| Hori, K; Saito, S | 1 |
| Hori, K | 1 |
| Delmonte, A; Sessa, C | 1 |
2 review(s) available for serine and fosbretabulin
| Article | Year |
|---|---|
Antineoplastic strategy: irreversible tumor blood flow stasis induced by the combretastatin A-4 derivative AVE8062 (AC7700).
Topics: Animals; Antineoplastic Agents; Microcirculation; Neoplasms; Rats; Regional Blood Flow; Serine; Stilbenes | 2005 |
AVE8062: a new combretastatin derivative vascular disrupting agent.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Neoplasms; Neovascularization, Pathologic; Serine; Stilbenes; Tubulin | 2009 |
3 other study(ies) available for serine and fosbretabulin
| Article | Year |
|---|---|
A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred ICR; Neoplasm Transplantation; Neoplasms, Experimental; Serine; Stilbenes; Survival Analysis; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.
Topics: Animals; Antineoplastic Agents; Blood Pressure; Body Weight; Disease Models, Animal; Drug Screening Assays, Antitumor; Lymphatic Metastasis; Male; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Regional Blood Flow; Serine; Stilbenes; Survival Rate | 1999 |
Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700).
Topics: Animals; Antineoplastic Agents, Phytogenic; Catecholamines; Epinephrine; Necrosis; Neoplasms, Experimental; Rats; Regional Blood Flow; Sarcoma; Serine; Soft Tissue Neoplasms; Stilbenes | 2004 |